Skip Navigation


Journal of Biochemistry Advance Access originally published online on May 4, 2009
Journal of Biochemistry 2009 146(2):283-293; doi:10.1093/jb/mvp068
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
146/2/283    most recent
mvp068v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Endo, T.
Right arrow Articles by Aoki, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Endo, T.
Right arrow Articles by Aoki, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Authors 2009. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved

Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood

Tomoko Endo1,2,*, Kuniyuki Kano2,*, Rie Motoki1,*, Kotaro Hama1, Shinichi Okudaira1,2, Mayuko Ishida3, Hideo Ogiso3, Masayuki Tanaka1,2, Norio Matsuki1, Ryo Taguchi3, Motomu Kanai1, Masakatsu Shibasaki1, Hiroyuki Arai1,4 and Junken Aoki2,5,{dagger}

1Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033; 2Graduate School of Pharmaceutical Sciences, Tohoku University, Aobayama, Aoba-ku, Sendai, 980-8578; 3Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033; 4CREST; and 5PRESTO, Japan Science and Technology Corporation, Japan

{dagger}To whom correspondence should be addressed. Tel: +81-3-5841-4723, Fax: +81-3-3818-3173, E-mail: jaoki{at}mail.pharm.tohoku.ac.jp

Received February 23, 2009; Accepted April 16, 2009


  Abstract

Lysophosphatidic acid (LPA) is a simple phospholipid but has numerous biological effects through a series of G-protein-coupled receptors specific to LPA. In general, LPA is short-lived when applied in vivo, which hinders most pharmacological experiments. In our continuing study to identify stable LPA analogues capable of in vivo applications, we identified here lysophosphatidylmethanol (LPM) as a stable and pan-LPA receptor agonist. A synthetic LPM activated all five LPA receptors (LPA1–5), and stimulates both cell proliferation and LPA-receptor-dependent cell motility. In addition, LPM showed a hypertensive effect in rodent when applied in vivo. We found that, when fetal calf serum was incubated in the presence of methanol, formation of LPM occurred rapidly, whereas it was completely blocked by depletion of autotaxin (ATX), a plasma enzyme that converts lysophosphatidylcholine (LPC) to LPA. When recombinant ATX was incubated with LPC in the presence of methanol, both LPM and LPA were produced with a ratio of 1:10, showing that ATX has transphosphatidylation activity in addition to its lysophospholipase D activity. Administration of methanol in mice resulted in the formation of several micromoles of LPM in plasma, which is much higher than that of LPA. The present study identified LPM as a novel and stable lysophospholipid mediator with LPA-like activities and ATX as a potential synthetic enzyme for LPM.

Key Words: lysophosphatidic acid, lysophosphatidylmethanol, lysophosphatidylcholine, autotaxin, transphosphatidylation

Abbreviations: LPA, lysophosphatidic acid; LPM, lysophosphatidylmethanol; LPC, lysophosphatidylcholine; ATX, autotaxin; LPEt, lysophosphatidylethanol; LPBt, lysophosphatidylbutanol; MS, mass spectrometry

*These authors contribute equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.